2026-09-17T09:05:53-07:00 2025-12-31 223849589 MCINTEE FUSARO DEL CORRAL LLC 277 FAIRFIELD RD STE 300 FAIRFIELD NJ 07004 990 2025-01-01 141717344 CLINICAL DIRECTORS NETWORK INC CLIN 2123820699 5 W 37TH ST NEW YORK NY 10018 JONATHAN N TOBIN PHD President & CEO 2026-09-17 true DARREN FUSARO CPA P01215680 9738820300 2025 JONATHAN N TOBIN PHD 5 W 37TH ST NEW YORK NY 10018 3327043 false X WWW.CDNETWORK.ORG X 1989 NY THE ORGANIZATION PROMOTES PROFESSIONAL EXCELLENCE AMONG ITS MEMBERSHIP, AND PROVIDES ACCREDITED CONTINUING MEDICAL (CME) DENTAL (CDE) NURSING (CNE), COMMUNITY HEALTH EDUCATION (CHES) AND SOCIAL WORK (CE-SW) EDUCATIONALACTIVITIES, BOTH IN PERSON AND ON-LINE, AS WELL AS CONDUCTING PRACTICE-BASED CLINICAL AND TRANSLATIONAL RESEARCH AND PUBLIC HEALTH PROGRAMS. 11 11 18 50 0 3403103 3184382 80510 52675 131251 89986 95309 0 3710173 3327043 0 0 1818622 1888611 0 4969 1662132 1314332 3480754 3202943 229419 124100 3328500 3823235 1473897 1844532 1854603 1978703 THE ORGANIZATION PROMOTES PROFESSIONAL EXCELLENCE AMONG ITS MEMBERSHIP, AND PROVIDES ACCREDITED CONTINUING MEDICAL (CME) DENTAL (CDE) NURSING (CNE), COMMUNITY HEALTH EDUCATION (CHES) AND SOCIAL WORK (CE-SW) EDUCATIONALACTIVITIES, BOTH IN PERSON AND ON-LINE, AS WELL AS CONDUCTING PRACTICE-BASED CLINICAL AND TRANSLATIONAL RESEARCH AND PUBLIC HEALTH PROGRAMS. false false 1662811 Guide to Improving Patient Safety in Primary Care settings by engaging patients and families - Get ready and empowered about treatment (GREAT2) implementation research: translating the ABCS into HIV care - Dynamically tailoring interventions for problem-solving in diabetes self managment using self-monitoring data (MODD2)- Building experience for treating trauma and enhancing resilience (BETTER) Project - BRIEF intervention to Evaluate Asthma Therapy (BREATHE) Study - Accredited Continuing Medical, dental, nursing community, health education and social work activities 503358 Preventing Tipping Points in High Comorbidity Patients: A Lifetime from Health CoachesProtecting the Mental and Physical Well-Being of Frontline Healthcare Workers during COVID-19: The Cover-HCW ProjectCollaborations for Health and Empowered Community-Based Scientists (CHECS)Patient-Centered HCV Care via Telemedicine for Individuals on Opiate Substitution Therapy: A stepped Wedge Cluster Randomized Controlled Trial 104163 SYNEOS - ER/LA - EXTENDED RELEASE/LONG ACTING OPIOID POST-MARKETING REQUIREMENT STUDIES TO PROVIDE QUATITATIVE ESTIMATES OF THE SERIOUS RISKS OF MISUSE, ABUSE, ADDICTION, OVERDOSE, AND DEATH ASSOCIATED WITH LONG-TERM USE OF OPIOID ANALGESICS FOR MANAGEMENT OFCHRONIC PAIN, AMONG PATIENTS PRESCRIBED ER/LA OPIOID PRODUCTS. 2270332 true true false false false false false false false false true false false true true true true false false false false false false false false false false false false true false false false false false false false false false false false false false true false false false true 29 0 true 18 true false false false false false false false 0 false false false false false false false X 11 11 false false false false false false false true true false false true true true true true true true true false NY X PROSPERITY PARTNERS 7325888764 555 US ROUTE ONE SOUTH ISELIN NJ 08830 JONATHAN N TOBIN PHD President & CEO 40.00 0.00 X 430808 0 82070 ANDREA N DONALDSON DIRECTOR OF CLINICAL AFFAIRS 40.00 0.00 197926 0 64253 LOIS BOOKHARDT-MURRAY Director 0.50 0.00 X 0 0 0 AVI SILBER MD Past Chairman 0.50 0.00 X X 0 0 0 REBECCA COLLINS DO MPH Chairperson 0.50 0.00 X X 0 0 0 SARA PALOMINO DNP RN FNP Director 0.50 0.00 X 0 0 0 KEMI ALLI MD Director 0.50 0.00 X 0 0 0 NANCY PIPER JENKS MS CFNP Director 0.50 0.00 X 0 0 0 WALID MICHELIN MD MPH Director 0.50 0.00 X 0 0 0 DEVIN GOODMAN DMD Treasurer 0.50 0.00 X X 0 0 0 MONICA M SWEENEY Director 0.50 0.00 X 0 0 0 ANITA C VAUGHN Director 0.50 0.00 X 0 0 0 RINA RAMIREZ Secretary 0.50 0.00 X X 0 0 0 628734 146323 2 false true false DORFMAN MIZRACH & THALER LLP 555 ROUTE 1 SOUTH ISELIN NJ 08830 ACCOUNTING 134644 1 1933688 1250694 3184382 Webcasts 611710 52675 52675 52675 89986 89986 0 0 0 0 0 0 0 0 3327043 52675 89986 0 0 0 0 628734 506618 119459 2657 0 822926 616000 205841 1085 155799 125407 29738 654 185020 135236 49717 67 96132 77266 18460 406 0 1080 1080 252924 252924 0 0 0 219725 211659 8066 0 97719 31081 66538 100 0 0 148726 148726 0 0 0 0 0 0 12557 12557 HEALTH CENTER SUBCONTRACTORS 269883 269883 ASSESSMENTS/INTERVENTION 235299 235299 TELEPHONE/WEBCASTS 26414 24130 2284 EQUIPMENT REPAIR AND MAINT 23334 12791 10543 26671 24962 1709 3202943 2270332 927642 4969 95764 224565 1705642 1802233 0 631502 1123375 0 0 0 0 33367 33343 201133 201133 0 0 0 0 0 862225 639719 3328500 3823235 377629 448750 1096268 1395782 1473897 1844532 X 1854603 1978703 1854603 1978703 3328500 3823235 124100 X false true X true true true X 3295965 3032840 3327746 2765121 2568518 14990190 0 0 3295965 3032840 3327746 2765121 2568518 14990190 0 14990190 5994 6474 76279 131251 89986 309984 0 0 15300174 3498344 0.97970 0.98460 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 14423 14423 183405 183405 3305 3305 employee retention credits right of use assets 604094 sECURITY DEPOSIT 35625 639719 LEASE LIABILITY 637709 LINE OF CREDIT 214969 REFUNDABLE ADVANCES 543104 1395782 X 3327043 3327043 3327043 3202943 3202943 3202943 Part X : FIN48 Footnote CLINICAL DIRECTORS NETWORK, INC. IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND THEREFORE, HAS MADE NO PROVISION FOR FEDERAL INCOME TAXES IN THE ACCOMPANYING FINANCIAL STATEMENTS. IN ADDITION, CLINICAL DIRECTORS NETWORK, INC. QUALIFIES FOR THE CHARITABLE CONTRIBUTION DEDUCTION UNDER SECTION 170(B)(1)(A)(VI) AND HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE NOT TO BE A "PRIVATE FOUNDATION" WITHIN THE MEANING OF SECTION 509 (A)(1) OF THE INTERNAL REVENUE CODE.CLINICAL DIRECTORS NETWORK, INC. REGULARLY REVIEWS AND EVALUATES ITS TAX POSITIONS TAKEN IN PREVIOUSLY FILED INFORMATION RETURNS WITH REGARDS TO ISSUES AFFECTING ITS TAX EXEMPT STATUS, UNRELATED BUSINESS INCOME AND OTHER RELATED MATTERS. THE MANAGEMENT OF CLINICAL DIRECTORS NETWORK, INC. BELIEVES THAT IN THE EVENT OF AN EXAMINATION BY A TAXING AUTHORITY, THEPOSITIONS TAKEN BY IT WOULD PREVAIL SUCH AN EXAMINATION. ACCORDINGLY, CLINICAL DIRECTORS NETWORK, INC. HAS CONCLUDED THAT NO TAX BENEFITS OR LIABILITIES ARE REQUIRED TO BE RECOGNIZED IN THE ACCOMPANYING FINANCIAL STATEMENTS.CLINICAL DIRECTORS NETWORK, INC. FILES FORM 990 "RETURN OF ORGANIZATION EXEMPT FROM INCOME TAXES", WHICH IS AN INFORMATION RETURN AND IS SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE (IRS) GENERALLY FOR THREE (3) YEARS AFTER THE RETURN IS FILED. AS OF THE REPORT DATE, FEDERAL FORMS 990 FOR CALENDAR YEARS 2022 THROUGH 2024 ARE OPEN TO EXAMINATION BY THE IRS. NO RETURNS ARE CURRENTLY UNDER EXAMINATION BY THE IRS. X X X X X false false false false false true false false false ANDREA N DONALDSON DIRECTOR OF CLINICAL AFFAIRS 197926 38107 26146 262179 JONATHAN N TOBIN PHD President & CEO 430808 62090 19980 512878 Form 990, Part VI, Section B, Line 11b A "DRAFT" COPY OF THE FORM 990 WAS SENT TO THE GOVERNING BOARD MEMBERS AND MANAGEMENT OF THE ORGANIZATION FOR THEIR REVIEW PRIOR TO ITS ISSUANCE AND FILING. THE BOARD WILL APPROVE THE 990 IN PERSON AT A BOARD MEETING. Form 990, Part VI, Section B, Line 12c THE ORGANIZATION ANNUALLY ISSUES A "CONFLICT OF INTEREST DISCLOSURE" FORM FOR ALL OF ITS BOARD MEMBERS TO SIGN. Form 990, Part VI, Section B, Line 15a THE ORGANIZATION'S POLICY IS TO PROVIDE FAIR COMPENSATION TO THE CEO AND TOP MANAGEMENT BASED ON SEVERAL FACTORS INCLUDING BUT NOT LIMITED TO: PERFORMANCE APPRAISAL OF THE CEO BY THE BOARD"MARKET RESEARCH" OF SALARIES FOR COMPARABLE POSITIONS, WHERE POSSIBLE AVOIDANCE OF CONFLICT OF INTEREST BY BOARD MEMBERS. FOR INSTANCE, IF A BOARD MEMBER IS A BENEFICIARY OF A GRANT WHICH IMPACTS DECISIONS REGARDINGCEO COMPENSATION, OR IF THAT MEMBER MAY BENEFIT FINANCIALLY FROM THE CEO'S COMPENSATION AGREEMENT, THE MEMBER SHOULD RECUSE HIMSELF/HERSELF FROM THE PROCESS.SHOULD COMPLY WITH IRS REGULATIONS.DETERMINATION OF COMPENSATION SHOULD BE TRANSPARENT.FREQUENCY: TO BE DETERMINED AS STIPULATED IN THE CEO EMPLOYMENT AGREEMENT/CONTRACT.COMPENSATION COMMITTEE: SHOULD BE COMPOSED OF EXECUTIVE COMMITTEE OF THE BOARD.COMPARABLES: COMMITTEE WILL REVIEW COMPARABLE SALARIES USING GUIDESTAR, OR OTHER SOURCES OF EXECUTIVE COMPENSATION. THIS COULD INCLUDE REVIEW OF U.S. FEDERAL FORM 990 REPORTS OF OTHER NON-PROFITS, OPINION OF AN INDEPENDENT CONSULTANT, INFORMAL CALLS TO OTHER NON-PROFIT ORGANIZATIONS.APPROVAL: THE CEO'S COMPENSATION MUST RECEIVE FINAL APPROVAL BY THE CDN BOARD OF DIRECTORS. THE PROCESS OF DETERMINATION OF THE CEO COMPENSATION IS THEN DOCUMENTED IN THE MINUTES OF THE BOARD GENERAL MEETING. Form 990, Part VI, Section C, Line 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICIES AND FINANCIAL STATEMENT ARE AVAILABLE TO THE PUBLIC UPON REQUEST. Quality Professional Systems Development N/A false QUALITY PROFESSIONAL SYSTEMS DEVELOPMENT 5 west 37th street NEW YORK NY 10018 133847431 CONSULTING NY N/A C CORP -758 3972 false false false false false false false false false false false false false false false false false false false false